Rep. Gosar Demands Accountability from Big Pharma Now
Submitted by MAGA
Posted 3 hours ago
**Accountability for Big Pharma: Rep. Gosar's Bold Move Against Vaccine Immunity**
In a daring legislative move, Republican U.S. Representative Paul Gosar of Arizona has introduced a bill aimed at dismantling longstanding immunities enjoyed by vaccine manufacturers.
The newly proposed End the Vaccine Carveout Act (H. R. 9828) seeks to empower individuals to pursue lawsuits against vaccine manufacturers and administrators for injuries or deaths linked to vaccinations.
This legislation stands in stark contrast to the protections enshrined in the federal National Childhood Vaccine Injury Act of 1986, which has historically shielded pharmaceutical companies from legal burden over their products.
In a press release, Gosar expressed strong concerns about the existing immunities that limit accountability for vaccine-related injuries, particularly in light of the widespread rollout of COVID-19 vaccines.
“Government bureaucrats and scientists responsible for approving vaccines are in bed with Big Pharma, often owning pharmaceutical stocks, serving as consultants, and receiving lucrative contracts that pressure them to produce favorable results,” Gosar stated.
His remarks come amid a growing body of evidence suggesting that adverse effects linked to COVID-19 vaccines have escalated rapidly. Reports from the Vaccine Adverse Event Reporting System (VAERS) show shocking numbers, including over 37,000 deaths and hundreds of thousands of hospitalizations.
The urgency of Gosar's proposal has been underscored by tragic personal accounts of individuals suffering severe health consequences after vaccination.
Take the case of triathlete Ingi Doyle, whose active lifestyle came to a halt following complications from the Pfizer vaccine.
Doyle, previously a model of health and fitness, suffered heart damage and underwent multiple surgeries after experiencing aortic dissection, which she believes was triggered by the vaccine.
These alarming narratives, alongside increasing skepticism about vaccine safety, highlight the need for transparency and accountability within the pharmaceutical industry.
Defenders of the new bill argue that it represents a necessary step toward protecting consumers and ensuring drug manufacturers uphold a standard of safety and efficacy.
The Biden administration has continued the trend of supporting vaccine rollouts amidst increasing scrutiny, disregarding growing public concerns surrounding vaccine safety and manufacturer accountability.
Gosar’s bill signals a proactive stance among Republican lawmakers, actively addressing the concerns of constituents who feel marginalized by the mainstream narrative surrounding vaccination.
As his legislation moves forward, the discussions surrounding vaccine safety, accountability, and government oversight are poised to take center stage, revealing the impact of Big Pharma's role in public health policies.
With continuing revelations about the entanglements of health authorities and drug companies, the fight for transparency could redefine the landscape of public health in America.
Sources:
lifesitenews.com
newsaddicts.com
naturalnews.com
In a daring legislative move, Republican U.S. Representative Paul Gosar of Arizona has introduced a bill aimed at dismantling longstanding immunities enjoyed by vaccine manufacturers.
The newly proposed End the Vaccine Carveout Act (H. R. 9828) seeks to empower individuals to pursue lawsuits against vaccine manufacturers and administrators for injuries or deaths linked to vaccinations.
This legislation stands in stark contrast to the protections enshrined in the federal National Childhood Vaccine Injury Act of 1986, which has historically shielded pharmaceutical companies from legal burden over their products.
In a press release, Gosar expressed strong concerns about the existing immunities that limit accountability for vaccine-related injuries, particularly in light of the widespread rollout of COVID-19 vaccines.
“Government bureaucrats and scientists responsible for approving vaccines are in bed with Big Pharma, often owning pharmaceutical stocks, serving as consultants, and receiving lucrative contracts that pressure them to produce favorable results,” Gosar stated.
His remarks come amid a growing body of evidence suggesting that adverse effects linked to COVID-19 vaccines have escalated rapidly. Reports from the Vaccine Adverse Event Reporting System (VAERS) show shocking numbers, including over 37,000 deaths and hundreds of thousands of hospitalizations.
The urgency of Gosar's proposal has been underscored by tragic personal accounts of individuals suffering severe health consequences after vaccination.
Take the case of triathlete Ingi Doyle, whose active lifestyle came to a halt following complications from the Pfizer vaccine.
Doyle, previously a model of health and fitness, suffered heart damage and underwent multiple surgeries after experiencing aortic dissection, which she believes was triggered by the vaccine.
These alarming narratives, alongside increasing skepticism about vaccine safety, highlight the need for transparency and accountability within the pharmaceutical industry.
Defenders of the new bill argue that it represents a necessary step toward protecting consumers and ensuring drug manufacturers uphold a standard of safety and efficacy.
The Biden administration has continued the trend of supporting vaccine rollouts amidst increasing scrutiny, disregarding growing public concerns surrounding vaccine safety and manufacturer accountability.
Gosar’s bill signals a proactive stance among Republican lawmakers, actively addressing the concerns of constituents who feel marginalized by the mainstream narrative surrounding vaccination.
As his legislation moves forward, the discussions surrounding vaccine safety, accountability, and government oversight are poised to take center stage, revealing the impact of Big Pharma's role in public health policies.
With continuing revelations about the entanglements of health authorities and drug companies, the fight for transparency could redefine the landscape of public health in America.
Sources:
lifesitenews.com
newsaddicts.com
naturalnews.com
Latest News